Skip to main content
Clinical Trials/CTRI/2022/10/046527
CTRI/2022/10/046527Not yet recruitingPhase 3

A CLINICAL OBSERVATIONAL STUDY TO FIND OUT THE EFFECTIVENESS OF HOMOEOPATHIC POTENTISED MEDICINE ZINCUM METALLICUM INREDUCING TSH VALUES OF HYPOTHYROID PATIENTS

DrGouthamy Sasikumar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients from 18 to 65 years of age, both genders
  • 2. Patient having increased TSH value from 5-50 uIu/ml.

Exclusion Criteria

  • Cases with marked TSH level variations above 50 uIu/ml, multi-nodular
  • goitres and malignant thyroid tumours.
  • Patients with other severe systemic illness like uncontrolled diabetes,
  • malignant hypertension, other malignancies etc.
  • Immuno-compromised patients (AIDS, Cancer, TB)
  • Pregnant women and lactating mothers

Investigators

Sponsor
DrGouthamy Sasikumar

Similar Trials